Perspective Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Perspective Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Perspective Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -26.2 %, a 0.87% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Return On Equity for 2023 was -46.4 %, a 155% decline from 2022.
  • Perspective Therapeutics, Inc. annual Return On Equity for 2022 was -18.2 %, a 106% decline from 2021.
  • Perspective Therapeutics, Inc. annual Return On Equity for 2021 was -8.83 %, a 84.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -26.2 +0.23 +0.87% Jul 1, 2024 Sep 30, 2024
Q2 2024 -31.7 -9.5 -42.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -45.6 -32.2 -240% Jan 1, 2024 Mar 31, 2024
Q4 2023 -46.4 -28.3 -155% Oct 1, 2023 Dec 31, 2023
Q3 2023 -26.4 -11.7 -79% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.2 -10.8 -94.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -13.4 -3.82 -39.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -18.2 -9.66 -113% Oct 1, 2022 Dec 31, 2022
Q3 2022 -14.8 -5.57 -60.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -11.4 -2.59 -29.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -9.6 +5.73 +37.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -8.51 +36.6 +81.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -9.19 +49.5 +84.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -8.83 +47.1 +84.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -15.3 +35.1 +69.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -45.1 +8.49 +15.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -58.7 -4.6 -8.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -56 -0.44 -0.79% Apr 1, 2020 Jun 30, 2020
Q1 2020 -50.4 +23.9 +32.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -53.6 +27.8 +34.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -54.1 +32.7 +37.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -55.5 +37.8 +40.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -74.3 -1.91 -2.64% Jan 1, 2019 Mar 31, 2019
Q4 2018 -81.4 -19 -30.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -86.8 -32.3 -59.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -93.3 -45.3 -94.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -72.4 -34 -88.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -62.4 -28.3 -83% Oct 1, 2017 Dec 31, 2017
Q3 2017 -54.5 -23.7 -77.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -48 -21.9 -84.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -38.4 -14.6 -61.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -34.1 -12.7 -59.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -30.8 -12.3 -66.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -26.1 -9.39 -56.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -23.8 -4.88 -25.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -21.4 +1.68 +7.28% Oct 1, 2015 Dec 31, 2015
Q3 2015 -18.5 +9.41 +33.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -16.7 +21.5 +56.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -18.9 +29.1 +60.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -23.1 +38 +62.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -27.9 +35.4 +55.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -38.1 +19.3 +33.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -48 +11.5 +19.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -61 -3.47 -6.03% Oct 1, 2013 Dec 31, 2013
Q3 2013 -63.3 -12.8 -25.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -57.4 +0.59 +1.02% Apr 1, 2013 Jun 30, 2013
Q1 2013 -59.5 -11 -22.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -57.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -50.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -58 Apr 1, 2012 Jun 30, 2012
Q1 2012 -48.5 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.